FDA 483 - Roman Skoracki MD - February 28, 2020

An FDA inspection of Roman Skoracki MD in Columbus, OH, identified a significant issue related to the conduct of an investigational plan. The firm failed to ensure that assessments were performed by qualified personnel as instructed in the protocol and that personnel were properly listed in the delegation of authority log. This indicates a lack of adherence to study protocols and proper oversight in clinical research.